13.00 - 13.20 Registration
13.20 - 13.30 Welcome
Miranda Weston-Smith, BioBeat, Sally Ann Forsyth, Stevenage Bioscience Catalyst, Victoria Higgins, GSK
13.30 - 14.00 Keynote address: Emma Walmsley, CEO, GSK - C> at GSK: Innovation and Value Creation
14.00-15.00 - Panel 1: Leveraging Science
This panel lives the translational journey from scientific innovation to scale up of C> and asks: where are the biggest opportunities?
Soraya Bekkali, Gyroscope, Tamsin Berry, Office of Life Sciences, Aisha Hasn, GSK, Emma Moris, UCL Institute of Immunity and Transplantation (Chair), Sophie Papa, King's College London
15.00-15.30 Break
15.30-16.30 - Panel 2: Optimising Value
This panel unwraps the drivers for value in C>, from commercial return to impact on health, and asks: how best to balance needs?
Karen Hodgkin, CellMedica (Chair), Jeanette Kusel, NICE, Anna Outhwaite, Cell and Gene Therapy Catapult, Tara Raveendran, Shore Capital, Jane Whitrow, Freeline Therapeutics
16.30 - 16.35 Close and Thanks
16.35-18.00 Refreshments and Networking
This half day event is for scientists, investors and entrepreneurs. Leading women will discuss opportunities and catalyse ideas with the audience. Open to all.
Please register at www.biobeat19.org.
